Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.360
+0.010 (0.43%)
At close: Apr 17, 2026, 4:00 PM EDT
2.368
+0.008 (0.33%)
After-hours: Apr 17, 2026, 5:44 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 1.40M | - | - | - | - | | | | | |
| 61.86M | 56.13M | 79.18M | - | - | | | | | |
| 10.20% | -29.11% | - | - | - | | | | | |
| - | 41.00K | 103.00K | - | - | | | | | |
| - | -60.19% | - | - | - | | | | | |
| - | 1.50M | 5.23M | - | - | | | | | |
| - | -71.31% | - | - | - | | | | | |
Dermatology Products Sales | - | - | - | 73.67M | 63.13M | | | | | |
Dermatology Products Sales Growth | - | - | - | 16.69% | 41.78% | | | | | |
Pharmaceutical and Biotechnology Product Development | - | - | - | 2.07M | 5.66M | | | | | |
Pharmaceutical and Biotechnology Product Development Growth | - | - | - | -63.34% | 429.68% | | | | | |
| 63.26M | 57.68M | 84.51M | 75.74M | 68.79M | | | | | |
| 9.69% | -31.76% | 11.58% | 10.11% | 50.86% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 63.26M | 57.68M | 84.51M | 75.74M | 68.79M | | | | | |
United States of America Growth | 9.69% | -31.76% | 11.58% | 10.11% | 50.86% | | | | | |
| 63.26M | 57.68M | 84.51M | 75.74M | 68.79M | | | | | |
| 9.69% | -31.76% | 11.58% | 10.11% | 50.86% | | | | | |
Source: S&P Global Market Intelligence.